Jesse Shustik

586 total citations
11 papers, 142 citations indexed

About

Jesse Shustik is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Jesse Shustik has authored 11 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Jesse Shustik's work include Multiple Myeloma Research and Treatments (7 papers), Cancer Treatment and Pharmacology (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Jesse Shustik is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Cancer Treatment and Pharmacology (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Jesse Shustik collaborates with scholars based in Canada, Switzerland and United States. Jesse Shustik's co-authors include Laurie H. Sehn, Joseph M. Connors, Brian Skinnider, Pedro Farinha, Gencheng Han, Christian Steidl, R. D. Gascoyne, Doug Horsman, Nathalie A. Johnson and Susana Ben Neriah and has published in prestigious journals such as Blood, Annals of Oncology and Haematologica.

In The Last Decade

Jesse Shustik

10 papers receiving 138 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesse Shustik Canada 5 114 78 50 27 26 11 142
Anupkumar George Australia 4 100 0.9× 65 0.8× 54 1.1× 42 1.6× 19 0.7× 6 143
Joel Wight Australia 8 104 0.9× 58 0.7× 43 0.9× 43 1.6× 24 0.9× 22 157
Yazeed Sawalha United States 8 99 0.9× 97 1.2× 53 1.1× 18 0.7× 24 0.9× 43 169
Henriette W Berenschot Netherlands 6 126 1.1× 103 1.3× 62 1.2× 20 0.7× 16 0.6× 11 164
Matthias Hänel Germany 6 109 1.0× 59 0.8× 78 1.6× 82 3.0× 16 0.6× 8 189
Allison Barraclough Australia 8 106 0.9× 87 1.1× 30 0.6× 35 1.3× 19 0.7× 29 152
Mitul Gandhi United States 8 133 1.2× 127 1.6× 80 1.6× 19 0.7× 34 1.3× 30 202
Barbara Mantoan Italy 7 106 0.9× 71 0.9× 53 1.1× 5 0.2× 28 1.1× 13 155
Olaf Determann Germany 4 195 1.7× 130 1.7× 82 1.6× 18 0.7× 21 0.8× 4 214
Susana Ben Neriah Canada 4 134 1.2× 80 1.0× 65 1.3× 44 1.6× 18 0.7× 5 158

Countries citing papers authored by Jesse Shustik

Since Specialization
Citations

This map shows the geographic impact of Jesse Shustik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse Shustik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse Shustik more than expected).

Fields of papers citing papers by Jesse Shustik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse Shustik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse Shustik. The network helps show where Jesse Shustik may publish in the future.

Co-authorship network of co-authors of Jesse Shustik

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse Shustik. A scholar is included among the top collaborators of Jesse Shustik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse Shustik. Jesse Shustik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bahlis, Nizar J., Christy Samaras, Donna Reece, et al.. (2024). Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014. Clinical Lymphoma Myeloma & Leukemia. 24(12). 852–862. 2 indexed citations
2.
Bahlis, Nizar J., Christy Samaras, Donna Reece, et al.. (2023). MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study. Clinical Lymphoma Myeloma & Leukemia. 23. S494–S495. 1 indexed citations
3.
4.
5.
Sébag, Michaël, Nizar J. Bahlis, Christopher P. Venner, et al.. (2019). A Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide with or without Pomalidomide in Patients with Relapsed and Refractory Multiple Myeloma. Blood. 134(Supplement_1). 3121–3121. 10 indexed citations
6.
7.
8.
Sehn, Laurie H., Karamjit Gill, Abdulwahab J. Al-Tourah, et al.. (2014). Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC). Blood. 124(21). 392–392. 23 indexed citations
9.
Shustik, Jesse, et al.. (2010). Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy. Annals of Oncology. 22(5). 1164–1169. 45 indexed citations
10.
Shustik, Jesse, Gencheng Han, Pedro Farinha, et al.. (2009). Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP. Haematologica. 95(1). 96–101. 50 indexed citations
11.
Shustik, Jesse, Michael Quinn, Joseph M. Connors, et al.. (2008). Follicular Non-Hodgkin Lymphoma Grade 3a and 3b Subtypes Exhibit Similar Clinical Behaviour and Treatment Outcome. Blood. 112(11). 3777–3777.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anupkumar George Breakdown of academic impact, for papers by Joel Wight Breakdown of academic impact, for papers by Yazeed Sawalha Breakdown of academic impact, for papers by Henriette W Berenschot Breakdown of academic impact, for papers by Matthias Hänel Breakdown of academic impact, for papers by Allison Barraclough Breakdown of academic impact, for papers by Mitul Gandhi Breakdown of academic impact, for papers by Barbara Mantoan Breakdown of academic impact, for papers by Olaf Determann Breakdown of academic impact, for papers by Susana Ben Neriah
Rankless by CCL
2026